Abstract
Schnitzler's syndrome (SS) is a rare inflammatory disease of unknown origin characterized by chronic urticaria and monoclonal gammopathy (usually IgM) associated with at least two of the following components: fever, arthralgia or arthritis, bone pain, hepato- and/or splenomegaly, lymphadenopathy, elevated erythrocyte sedimentation rate, leukocytosis, and/or abnormal findings on bone morphological investigations. To date, about 100 cases have been described with only 4 being reported in the USA. The mean time to diagnosis from the onset of disease is 5.4 years, given the varied symptoms with which patients may present. The pathogenesis of SS remains unknown but likely involves dysregulation of the IL-1 pathway. We describe here a 48-year-old woman with a monoclonal IgM gammopathy and a 3-year history of chronic pruritic urticarial dermatosis, unexplained fevers, chronic polyarthritis, lymphadenopathy, leukocytosis, hepatomegaly, and weight loss. She also had a history of chronic pancreatitis as well as a family history of recurrent pancreatitis. The diagnosis of Schnitzler's syndrome was made, and she was successfully treated with the IL-1 receptor antagonist, anakinra.
Similar content being viewed by others
References
Lipsker D, Veran Y, Grunenberger F, Cribier B, Heid E, Grosshans E (2001) The Schnitzler syndrome. Four new cases and review of the literature. Medicine (Baltimore) 80:37–44
de Koning HD, Bodar EJ, van der Meer JW, Simon A, Schnitzler Syndrome Study Group (2007) Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment. Semin Arthritis Rheum 37:137–148
Dinarello CA (2009) Interleukin-1beta and the autoinflammatory diseases. N Engl J Med 360:2467–2470
Gabay C, Lamacchia C, Palmer G (2010) IL-1 pathways in inflammation and human diseases. Nat Rev Rheumatol 6:232–241
Aksentijevich I, Masters SL, Ferguson PJ, Dancey P, Frenkel J, van Royen-Kerkhoff A et al (2009) An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med 360:2426–2437
Saurat JH, Schifferli J, Steiger G, Dayer JM, Didierjean L (1991) Antiinterleukin-1 alpha autoantibodies in humans: characterization, isotype distribution and receptor-binding inhibition-higher frequency in Schnitzler's syndrome (urticaria and macroglobulinemia). J Allergy Clin Immunol 88:244–256
Ryan JG, de Koning HD, Beck LA, Booty MG, Kastner DL, Simon A (2008) IL-1 blockade in Schnitzler syndrome: ex vivo findings correlate with clinical remission. J Allergy Clin Immunol 121:260–262
de Kleijn EM, Telgt D, Laan R (1997) Schnitzler's syndrome presenting as fever of unknown origin (FUO). The role of cytokines in its systemic features. Neth J Med 51:140–142
Migliorini P, Corso ID, Tommasi C, Boraschi D (2009) Free circulating interleukin-18 is increased in Schnitzler syndrome: a new autoinflammatory disease? Eur Cytokine Netw 20:108–111
Pizzirani C, Falzoni S, Govoni M, La Corte R, Donadei S, Di Virgilio F et al (2009) Dysfunctional inflammasome in Schnitzler's syndrome. Rheumatology 48:1304–1308
Loock J, Lamprecht P, Timmann C, Mrowietz U, Csernok E, Gross WL (2010) Genetic predisposition (NLRP3 V198M mutation) for IL-1-mediated inflammation in a patient with Schnitzler syndrome. J All Clin Immunol 125:500–502
Lipsker D, Spehner D, Drillien R, Schmitt P, Cribier B, Heid E et al (2000) Schnitzler syndrome: heterogeneous immunopathological findings involving IgM-skin interactions. Br J Dermatol 142:954–959
Nashan D, Sunderkötter C, Bonsmann G, Luger T, Goerdt S (1995) Chronic urticaria, arthralgia, raised erythrocyte sedimentation rate and IgG paraproteinaemia: a variant of Schnitzler's syndrome? Br J Dermatol 133:132–134
Rizzi R, Curci P, Rinaldi E, Rinaldi F, Cimmino A, Ricco R et al (2008) Schnitzler's syndrome: monoclonal gammopathy associated with chronic urticaria. Acta Haematol 120(1):1–4
Tanneberger O, Büchner S, Zimmerli LU (2007) Schnitzler's syndrome with urticaria vasculitis. Internist (Berl) 48:1432–1435
Kyle RA, Therneau TM, Rajkumar SV, Remstein ED, Offord JR, Larson DR et al (2003) Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Blood 102:3759–3764
Verret JL, Leclech C, Rousselet MC, Hurez D, Schnitzler L (1993) Schnitzler syndrome and Waldenström disease. Fatal outcome of the original case. Ann Dermatol Venereol 120:459–460
Blaise S (2003) Sensitive chonic inflammatory demyelinating polyradiculoneuropathy in Schnitzler's syndrome. Ann Dermatol Venereol 130:348–351
Lebbe C, Rybojad M, Klein F, Oksenhendler E, Catala M, Danon F et al (1994) Schnitzler syndrome associated with sensorimotor neuropathy. J Am Acad Dermatol 30:316–318
Worm M, Kolde G (2003) Schnitzler's syndrome: successful treatment of two patients using thalidomide. Br J Dermatol 148:601–602
Ramadan KM, Eswedi HA, El-Agnaf MR (2007) Schnitzler syndrome: a case report of successful treatment using the anti-CD20 monoclonal antibody rituximab. Br J Dermatol 156:1072e4
Murota H, Shoda Y, Ishibashi T, Sugahara H, Matsumura I, Katayama I (2009) Improvement of recurrent urticaria in a patient with Schnitzler syndrome associated with B-cell lymphoma with combination rituximab and radiotherapy. J Am Acad Derm 61:1070–1075
Besada E, Nossent H (2010) Dramatic response to IL1-RA treatment in longstanding multidrug resistant Schnitzler's syndrome: a case report and literature review. Clin Rheumatol 29:567–571
Mertens M, Singh JA (2009) Anakinra for rheumatoid arthritis. Cochrane Database Syst Rev 1:CD005121
Sediva A, Polouckova A, Podrazil M, Fronkova E, Kalina T (2010) Characterization of the B-cell compartment in a patient with Schnitzler syndrome. Scand J Rheumatol 0:1–3
Lust JA, Lacy M, Zeldenrust SR, Dispenzieri A, Gertz M, Witzig TE et al (2009) Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1β-induced interleukin-6 production and the myeloma proliferative component. Mayo Clin Proc 84:114–122
Dinarello C (2009) Targeting the pathogenic role of interleukin 1β in the progression of smoldering/indolent myeloma to active disease. Mayo Clin Proc 84:105–107
Nishida A, Andoh A, Imaeda H, Inatomi O, Shiomi H, Fujiyama Y (2010) Expression of interleukin 1-like cytokine interleukin 33 and its receptor complex (ST2L and IL1RAcP) in human pancreatic myofibroblasts. Gut 59:531–541
Smithies AM, Sargen K, Demaine AG, Kingsnorth AN (2000) Investigation of the interleukin 1 gene cluster and its association with acute pancreatitis. Pancreas 20:234–240
Norman J (1995) Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery 117:648–655
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Larocca, C.A., McEvoy, J.W., Ellis, C.L. et al. Schnitzler's syndrome associated with pancreatitis: a disease of IL-1 dysregulation. Clin Rheumatol 31, 169–174 (2012). https://doi.org/10.1007/s10067-011-1804-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-011-1804-4